The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation
Life · 24.09.2024 · 14 (10) · 1219
DOI: 10.3390/life14101219 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 24.09.2024. Verfasst von Konstantin A Rumyantsev und 6 weiteren Autor:innen. Beteiligte Einrichtung: Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Moscow Government under, Moscow Government.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The gut microbiota’s pivotal role in human health is increasingly evident, particularly in chronic conditions like obesity, diabetes, and inflammatory diseases. This intricate symbiotic relationship influences metabolic balance and immune responses. Notably, gut microbial dysbiosis is linked to obesity’s metabolic disruption and chronic low-grade inflammation. Similarly, in diabetes, the microbiota’s impact on insulin resistance and glucose metabolism is becoming evident. Chronic inflammation, a common denominator in these conditions, is also a recognized precursor to carcinogenesis. This intersection prompts a compelling question: does the gut microbiota’s influence extend to gastrointestinal cancers like colorectal and pancreatic cancer? These malignancies are closely intertwined with inflammation and metabolic dysregulation. Exploring whether the microbial signatures associated with chronic conditions overlap with precancerous or cancerous states offers new perspectives. This article reviews emerging evidence on the interplay between the gut microbiota, chronic conditions, and gastrointestinal cancers. By elucidating these connections, we aim to uncover potential avenues for innovative diagnostic, preventative, and therapeutic strategies in colorectal and pancreatic cancer management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
ORCID-Profile: Konstantin A Rumyantsev
Förderung
- This work was supported by the Moscow Government under
- Moscow Government
Zitieren
APA
Rumyantsev, K. A., Polyakova, V. V., Sorokina, I. V., Feoktistova, P. S., Khatkov, I. E., Bodunova, N. A., & Zhukova, L. G. (2024). The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation. Life, 14(10), 1219. https://doi.org/10.3390/life14101219
Vancouver
Rumyantsev KA, Polyakova VV, Sorokina IV, Feoktistova PS, Khatkov IE, Bodunova NA, et al. The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation. Life. 2024;14(10):1219. doi:10.3390/life14101219
BibTeX
@article{Rumyantsev2024,
author = {Rumyantsev, Konstantin A and Polyakova, Vera V and Sorokina, Irina V and Feoktistova, Polina S and Khatkov, Igor E and Bodunova, Natalia A and Zhukova, Lyudmila G},
title = {The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation},
journal = {Life},
year = {2024},
volume = {14},
number = {10},
pages = {1219},
doi = {10.3390/life14101219}
}
EUVIMED